XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Net sales $ 486,277 $ 485,121
Cost of goods sold 207,695 207,510
Gross profit 278,582 277,611
Selling, general and administrative expense 171,293 167,763
Research and development expense 52,923 42,730
Segment profit (loss) 54,366 67,118
Interest expense 13,196 16,766
Foreign exchange losses, net 1,441 3,042
Other (income) expense, net (6,450) (951)
Income before income taxes 46,179 48,261
Provision for income taxes (15,235) (15,323)
Net income including noncontrolling interests 30,944 32,938
Net loss (income) attributable to noncontrolling interests 61 101
Net income attributable to Bio-Rad $ 31,005 $ 33,039
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad $ 1.10 $ 1.18
Weighted average common shares - basic 28,201 27,904
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad $ 1.09 $ 1.16
Weighted average common shares - diluted 28,553 28,389